Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Idioma
Intervalo de año de publicación
1.
Voen Med Zh ; 335(5): 26-31, 2014 May.
Artículo en Ruso | MEDLINE | ID: mdl-25286560

RESUMEN

Authors consider causes of low efficiency of antidote therapy and ways of pharmacological tolerance management during medical treatment of organophosphate poisoning. One of the promising ways is a preventive antidote on the base of enzyme agents and allosteric modulators of a cholinesterase activity. Authors showed a expediency of a study of new acetylcholinesterase reactivators, its compositions and ways of drug delivery. Authors specified ways of searching for anticonvulsants from classes of quick-closing benzodiatines and NMDA-antagonists. Authors defined ways of improvement of methods of special antidotes delivery with targeted transport system. Authors made an assumption about the necessity of symptomatic treatment.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Antídotos/uso terapéutico , Sustancias para la Guerra Química/envenenamiento , Sistemas de Liberación de Medicamentos/métodos , Resistencia a Medicamentos/efectos de los fármacos , Intoxicación por Organofosfatos/tratamiento farmacológico , Acetilcolinesterasa/metabolismo , Humanos , Intoxicación por Organofosfatos/enzimología , Receptores de N-Metil-D-Aspartato/agonistas
2.
Eksp Klin Farmakol ; 76(2): 3-5, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-23631274

RESUMEN

The effect of memantine administration has been studied on the model of mice poisoning with an anticholinesterase compound. It is established that the memantine action is due to its influence on the cholinesterase activity in the brain, blood plasma, and erythrocytes in addition to its NMDA-blocking action. Memantine promotes oxime-induced erythrocyte enzyme reactivation on the model of mice poisoning with anticholinesterase compound (0.8 LD50).


Asunto(s)
Anticonvulsivantes/farmacología , Reactivadores de la Colinesterasa/farmacología , Memantina/farmacología , Intoxicación por Organofosfatos/tratamiento farmacológico , Acetilcolinesterasa/metabolismo , Animales , Anticonvulsivantes/metabolismo , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Butirilcolinesterasa/metabolismo , Inhibidores de la Colinesterasa/envenenamiento , Reactivadores de la Colinesterasa/metabolismo , Eritrocitos/efectos de los fármacos , Eritrocitos/enzimología , Isoflurofato/envenenamiento , Dosificación Letal Mediana , Masculino , Memantina/metabolismo , Ratones , N-Metilaspartato/antagonistas & inhibidores , N-Metilaspartato/metabolismo , Intoxicación por Organofosfatos/sangre , Oximas/metabolismo
3.
Eksp Klin Farmakol ; 76(1): 21-4, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-23461011

RESUMEN

The kinetics of oxime-induced reactivation of malathion-inhibited cholinesterase has been experimentally studied in vitro. It is shown that oximes do not restore the activity of inhibited butyrylcholinesterase. Acetylcholinesterase reactivation peak (5-mins long) was found to take place upon introduction of dipyroxime (32.5%), pralidoxime (18%), carboxyme (16%) at a concentration of 2.5 x 10(-4) mol/l or toxogonine (26%) at a concentration of 5 x 10(-4) mol/l. Toxogonine demonstrated the maximum affinity to phosphorylated enzyme, while dipyroxime is characterized by a high reactivity with respect to oxime. Significant reactivating ability of these preparations (kR -2300 mol(-1) min(-1) makes them promising solution for the treatment of malathion intoxication.


Asunto(s)
Acetilcolinesterasa/química , Antídotos/química , Butirilcolinesterasa/química , Inhibidores de la Colinesterasa/química , Reactivadores de la Colinesterasa/química , Malatión/química , Animales , Activación Enzimática , Eritrocitos/química , Eritrocitos/enzimología , Caballos , Cinética , Cloruro de Obidoxima/química , Compuestos de Pralidoxima/química , Soluciones , Torpedo , Trimedoxima/química
4.
Eksp Klin Farmakol ; 76(11): 19-22, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-24555228

RESUMEN

The tolerance of five central muscarinic receptor antagonists has been studied in experimental animals. According to the effect on orientation-exploratory reaction, drugs were arranged in the following order of increasing toxicity: procyclidine < trihexiphenidyl < benactizine < atropine < scopolamine. For the same therapeutic index, trihexiphenidyl and benactizine were characterized by the maximum tolerance (TD50/ED50 > 10) in mice. Scopolamine and atropine exhibited anticonvulsant activity at doses exceeding the threshold values by a factor of 6.3 and 3.9, respectively. For procyclidine, the average anticonvulsant dose was threefold lower than the threshold value. Benactizine and procyclidine had maximum tolerance levels in rats. The TD50/ED50 ratio for these drugs was greater than 3 (against 0.5 - 0.7 in groups treated with trihexiphenidyl, atropine and scopolamine).


Asunto(s)
Anticonvulsivantes/farmacología , Dosis Máxima Tolerada , Antagonistas Muscarínicos/farmacología , Animales , Masculino , Ratones , Ratas
5.
Eksp Klin Farmakol ; 75(9): 21-4, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-23156083

RESUMEN

The effect of an angiotensin receptor II antagonist (losartan) on the model acute renal failure (ARF) induced by severe ethylene glycol poisoning at 2/3 LD50 has been studied in rats. It is established that losartan administration (20 mg/kg for 72 h) produces a significant (4-fold) increase in the animal death rate, which is associated with ARF transition to a decompensation stage. Pronounced changes in the qualitative and quantitative composition of diurnal diuresis, more than 8-fold increase in the creatinine level, and 18-fold increase in the blood urea have been observed. Thus, the administration of losartan to ethylene glycol poisoned rats causes more pronounced degeneration of proximal tubule epithelium and destruction of glomeruli. It is concluded that the use of losartan for the treatment of ARF is inexpedient.


Asunto(s)
Lesión Renal Aguda/inducido químicamente , Lesión Renal Aguda/tratamiento farmacológico , Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología , Glicol de Etileno/envenenamiento , Losartán/farmacología , Lesión Renal Aguda/metabolismo , Lesión Renal Aguda/patología , Animales , Diuresis/efectos de los fármacos , Mesangio Glomerular/metabolismo , Mesangio Glomerular/patología , Túbulos Renales Proximales/metabolismo , Túbulos Renales Proximales/patología , Masculino , Ratas , Ratas Wistar
6.
Eksp Klin Farmakol ; 75(1): 27-9, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-22442960

RESUMEN

Combined administration of caffeine and ketorolac (NSAID) is accompanied by all possible types of drug interaction. Side effects of the drug combination are mostly due to the action of ketorolac and manifested by decompensated renal failure and progressive endotoxemia within 3 - 7 days after single administration of drugs. Thus, the amplification of ketorolac effects by caffeine must be taken into consideration in prescribing NSAIDs.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Cafeína/efectos adversos , Incompatibilidad de Medicamentos , Ketorolaco/efectos adversos , Insuficiencia Renal/inducido químicamente , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Cafeína/administración & dosificación , Interacciones Farmacológicas , Ketorolaco/administración & dosificación , Masculino , Ratas
7.
Eksp Klin Farmakol ; 74(7): 30-2, 2011.
Artículo en Ruso | MEDLINE | ID: mdl-21894766

RESUMEN

The antioxidant properties of sulfur-containing substances have been experimentally studied in vitro. Unithiol exhibits a wide spectrum us radicals. For this reason, unithiol can be considered, along with ascorbic acid, as a universal drug for the reduction of free radical reactions.


Asunto(s)
Antioxidantes/farmacología , Quelantes/farmacología , Hierro/metabolismo , Unitiol/farmacología , Ácido Ascórbico/farmacología , Compuestos de Bifenilo/metabolismo , Radicales Libres/metabolismo , Peróxido de Hidrógeno/metabolismo , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Picratos/metabolismo , Soluciones/química , Espectrofotometría , Azufre/química , Tiosulfatos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA